VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,531,000 | +519.8% | 194,800 | +324.4% | 0.02% | +566.7% |
Q1 2018 | $731,000 | -90.5% | 45,900 | -87.5% | 0.00% | -90.9% |
Q4 2017 | $7,708,000 | +125.1% | 368,617 | +53.9% | 0.03% | +120.0% |
Q3 2017 | $3,425,000 | -74.3% | 239,525 | -68.8% | 0.02% | -75.0% |
Q2 2017 | $13,346,000 | +23314.0% | 768,929 | +14977.0% | 0.06% | – |
Q1 2017 | $57,000 | -94.4% | 5,100 | -92.7% | 0.00% | -100.0% |
Q4 2016 | $1,009,000 | -90.3% | 69,500 | -83.7% | 0.01% | -90.4% |
Q3 2016 | $10,411,000 | +177.8% | 425,100 | +127.5% | 0.05% | +173.7% |
Q2 2016 | $3,748,000 | +4527.2% | 186,884 | +5928.5% | 0.02% | – |
Q1 2016 | $81,000 | -72.4% | 3,100 | +6.9% | 0.00% | -100.0% |
Q4 2015 | $293,000 | -25.1% | 2,900 | +31.8% | 0.00% | 0.0% |
Q3 2015 | $391,000 | -34.7% | 2,200 | -18.5% | 0.00% | -33.3% |
Q2 2015 | $599,000 | – | 2,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |